Assembly Biosciences CEO granted 50,750 RSUs
ASSEMBLY BIOSCIENCES, INC.
Rhea-AI Filing Summary
ASSEMBLY BIOSCIENCES, INC. CEO and President Jason A. Okazaki received a grant of 50,750 shares of common stock in the form of restricted stock units at no cash cost. These RSUs were approved on March 29, 2026 and became issuable after stockholders approved an amendment to the company’s 2018 Stock Incentive Plan on June 4, 2026.
The RSUs vest in four approximately equal annual installments on March 29, 2027, 2028, 2029, and 2030, subject to continued service. After this award, Okazaki directly holds 163,354 shares of common stock, including 688 shares acquired through the company’s Employee Stock Purchase Plan on May 14, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,750 shares
Grant/Award
1 txn
Insider
Okazaki Jason A
Role
CEO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,750 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 163,354 shares (Direct)
Footnotes (2)
- F1. Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increased the number of shares of common stock authorized for issuance under the Plan (the "Plan Amendment"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030.
- F2. Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026.
Key Figures
RSUs granted: 50,750 shares
Grant price: $0.00 per share
Post-grant holdings: 163,354 shares
+3 more
6 metrics
RSUs granted
50,750 shares
Restricted stock units granted March 29, 2026
Grant price
$0.00 per share
RSU award to CEO Jason A. Okazaki
Post-grant holdings
163,354 shares
Total common stock held directly after transaction
ESPP shares included
688 shares
Acquired under Employee Stock Purchase Plan on May 14, 2026
Vesting schedule
4 annual installments
Vesting on March 29, 2027, 2028, 2029, 2030
Plan approval date
June 4, 2026
Stockholders approved amendment to 2018 Stock Incentive Plan
Key Terms
Restricted stock units ("RSUs"), annual equity grant, Amended and Restated 2018 Stock Incentive Plan, Plan Amendment, +1 more
5 terms
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
annual equity grant financial
"RSUs representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026"
Amended and Restated 2018 Stock Incentive Plan regulatory
"amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan")"
Plan Amendment regulatory
"authorized for issuance under the Plan (the "Plan Amendment")"
Employee Stock Purchase Plan financial
"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ASMB CEO Jason Okazaki receive in this insider transaction?
Jason Okazaki received 50,750 restricted stock units of Assembly Biosciences common stock as part of his annual equity grant. The RSUs were granted at no cash cost and are a compensation award rather than an open-market share purchase or sale.
When do Jason Okazaki’s new ASMB restricted stock units vest?
The 50,750 restricted stock units granted to Jason Okazaki vest in four approximately equal annual installments. Vesting dates are March 29, 2027, March 29, 2028, March 29, 2029, and March 29, 2030, assuming he continues to provide service through each vesting date.
What approval was required for Jason Okazaki’s ASMB RSU award?
The RSU award depended on stockholders approving an amendment to Assembly Biosciences’ Amended and Restated 2018 Stock Incentive Plan. This amendment increased shares authorized under the plan and was approved on June 4, 2026, after which the RSUs became issuable to Okazaki.
Are Jason Okazaki’s ASMB RSUs an open-market purchase or sale?
The RSUs are a compensation award, not an open-market trade. They were granted at a price of $0.00 per share as part of his annual equity grant, contingent on stockholder approval of additional shares under the company’s stock incentive plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
